长期护理机构耐碳青霉烯菌污水监测方法评估
该研究评估长期护理机构污水采样检测碳青霉烯酶基因的可行性,16个月内采用定量PCR或GeneXpert Carba-R检测污水及生物膜样本,并与临床感染比较。blaKPC、blaOXA-48-like和blaVIM在复合污水、被动采样及下水道生物膜拭子中常规检出,但研究期间临床感染少且生物膜贡献使污水与临床发病率关联复杂。
要点
- 长期护理机构污水可常规检出blaKPC、blaOXA-48-like和blaVIM基因。
- 污水与下水道生物膜resistome不同,但均含blaKPC、blaVIM和blaIMP。
- 临床感染少及生物膜干扰使污水监测与临床发病率关联尚不明确。
核心结论
- 污水监测碳青霉烯酶在长期护理机构具可行性,但与临床感染关联需进一步研究。
研究设计与样本
- 16个月内在长期护理机构评估污水采样,用定量PCR或GeneXpert Carba-R检测碳青霉烯酶基因,并与临床感染比较。
主要发现
- blaKPC、blaOXA-48-like和blaVIM在复合污水样本、被动样本和下水道生物膜拭子中常规检出。
- 污水与下水道生物膜resistome不同,但均含blaKPC、blaVIM和blaIMP。
- 研究期间临床感染少,且下水道生物膜贡献使污水测量与临床发病率相关性复杂。
临床怎么用
- 可考虑在长期护理机构用污水采样监测碳青霉烯酶基因,但解读结果需结合临床感染和生物膜影响。
局限性
- 研究期间临床感染少,限制污水测量与临床发病率关联分析。
- 下水道生物膜贡献使污水监测与临床 incidence 相关性复杂化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Carbapenem resistance in bacteria is an urgent public health threat. Wastewater surveillance could support antimicrobial resistance monitoring at long-term care facilities. We assessed feasibility of wastewater sampling at such facilities for carbapenemase genes (blaKPC, blaVIM, blaOXA-48-like, blaNDM, and blaIMP) detected by quantitative PCR or GeneXpert Carba-R (Cepheid, https://www.cepheid.com) over 16 months and compared those findings with those for clinical infections. The blaKPC, blaOXA-48-like, and blaVIM genes were routinely detected in composite wastewater samples, passive samples, and sewer biofilm swab specimens. Wastewater and sewer biofilm resistomes differed, but both contained blaKPC, blaVIM, and blaIMP. Wastewater surveillance for carbapenemases shows promise, but few clinical infections during the study period and contributions from sewer biofilms complicate correlations between wastewater measurements and clinical incidence, underscoring the need for further research.
引用
- Warren E, VanDerslice J, Benson LS, et al. Evaluation of Detection Methods for Wastewater Surveillance of Antimicrobial-Resistant Bacteria from Healthcare Facilities. Emerg Infect Dis. 2026. PMID: 42536798. doi:10.3201/eid3213.251490
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。